224 related articles for article (PubMed ID: 19503102)
1. The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.
Linz W; Wohlfart P; Baader M; Breitschopf K; Falk E; Schäfer HL; Gerl M; Kramer W; Rütten H
Acta Pharmacol Sin; 2009 Jul; 30(7):935-46. PubMed ID: 19503102
[TBL] [Abstract][Full Text] [Related]
2. AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats.
Schäfer HL; Linz W; Falk E; Glien M; Glombik H; Korn M; Wendler W; Herling AW; Rütten H
Acta Pharmacol Sin; 2012 Jan; 33(1):82-90. PubMed ID: 22212431
[TBL] [Abstract][Full Text] [Related]
3. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Wu L; Wang W; Dai M; Li H; Chen C; Wang D
BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
[TBL] [Abstract][Full Text] [Related]
4. Auraptene, a citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPARα in rats.
Sunagawa Y; Kawaguchi S; Miyazaki Y; Katanasaka Y; Funamoto M; Shimizu K; Shimizu S; Hamabe-Horiike T; Kawase Y; Komiyama M; Mori K; Murakami A; Hasegawa K; Morimoto T
Phytomedicine; 2022 Dec; 107():154457. PubMed ID: 36223697
[TBL] [Abstract][Full Text] [Related]
5. The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
Lygate CA; Hulbert K; Monfared M; Cole MA; Clarke K; Neubauer S
Cardiovasc Res; 2003 Jun; 58(3):632-7. PubMed ID: 12798436
[TBL] [Abstract][Full Text] [Related]
6. Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats.
Wu L; Wang R; De Champlain J; Wilson TW
Am J Hypertens; 2004 Sep; 17(9):749-56. PubMed ID: 15363815
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
[TBL] [Abstract][Full Text] [Related]
8. Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha.
Qu C; Leung SW; Vanhoutte PM; Man RY
Eur J Pharmacol; 2012 Dec; 696(1-3):101-10. PubMed ID: 23022336
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
10. Late treatment with ramipril increases survival in old spontaneously hypertensive rats.
Linz W; Wohlfart P; Schoelkens BA; Becker RH; Malinski T; Wiemer G
Hypertension; 1999 Aug; 34(2):291-5. PubMed ID: 10454456
[TBL] [Abstract][Full Text] [Related]
11. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Rose M; Balakumar P; Singh M
Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
14. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
16. Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure.
Michel JB
Eur Heart J; 1990 May; 11 Suppl D():17-26. PubMed ID: 2141818
[TBL] [Abstract][Full Text] [Related]
17. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
18. Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat : effects of ramipril and hydralazine.
Nguyen T; El Salibi E; Rouleau JL
Circulation; 1998 Nov; 98(19):2074-80. PubMed ID: 9808607
[TBL] [Abstract][Full Text] [Related]
19. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
